[1]
Y. Feng, “Research Progress on Multiple Effects and Clinical Application of Proprotein Convertase Subtilisin-kexin9 Inhibitors”, jmhs, vol. 5, no. 2, pp. 54–58, Apr. 2024, doi: 10.32996/jmhs.2024.5.2.6.